Previous Close | 0.77 |
1-Year Change | -7.23% |
6-Months Change | 30.51% |
3-Months Change | -1.28% |
Moving Avg (50d) | 0.8714 |
Moving Avg (200d) | 0.8557 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 68.7M |
Beta (3-Years) | 0.94 |
Revenue Growth (ttm) | -71.34% |
Net Profit Margin (ttm) | -820.83% |
Return On Assets (ttm) | -198.19% |
EPS (ttm) | -1.54 |
PE Ratio (ttm) | -0.5 |
Dividend Yield | % |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Pharmaceuticals |
Country: | United States |